Virtual Cardiovascular Nursing Symposium Schedule

All times are listed in Central Time.

WEDNESDAY, MAY 20
Start at 11:00 AM ET, 10:00 AM CT, 9:00 AM MT, 8:00 AM PT
10:00 AMWelcome and PCNA Presidential Address
Kim Newlin, RN, MS, CNS, ANP
10:20 AMVirtual Symposium Overview and Pre-Assessment
10:30 AMSGLT2 Inhibitors and Cardiovascular Outcomes
Darren McGuire, MD, MHSc; Cindy Lamendola RN, MS, ANP
11:30 AMGLP1 Agonists and Cardiovascular Outcomes
Eryn Bryant, RN, MS, ANP
12:00 PMBreak
12:15 PMNon-CE Symposium from Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA - The Continuum of Heart Failure
1:00 PMBreak
1:15 PMInflammation and Cardiovascular Disease: Understanding the Relationship
Donna Arnett, PhD
2:00 PMOral Abstract Presentation
Innovative Project: Matters of the Heart – Navigating Resources to Assist Patients in Managing Cardiovascular Conditions
Pat Jolley
2:15 PMBreak
2:30 PMCurrent Trends in the Diagnosis and Management of Ischemic Heart Disease and Microvascular Angina
Eileen Handberg, PhD, ARNP-BC, FACC
3:15 PMDay 1 Post-Assessment and Wrap-Up
THURSDAY, MAY 21
Start at 10:15 AM ET, 9:15 AM CT, 8:15 AM MT, and 7:15 AM PT
9:15 AMWelcome: Key Learnings from Day 1 and Pre-Assessment Day 2
9:20 AMProduct Theater from Amgen
Cardiovascular Patient Cases
Janice McAlister, DNP, APRN, CLS
10:05 AMBreak
10:15 AMSex Differences in Prevention and Management of Heart Failure
Mariell Jessup, MD
11:00 AMLipid Management in 2020: The Role of Non-Statin Therapies
Susan Halli-Demeter, RN, DNP, CLS
11:45 AMBreak
12:00 PMProduct Theater from Esperion - NEXLETOL: A New, Oral, Nonstatin Therapy for Lowering LDL-C
Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA
12:45 PMBreak
1:00 PMOral Poster Presentation
Original Research: Symptoms, Functional Capacity, and Skeletal Muscle in Persons with Heart Failure with Preserved Ejection Fraction
Brittany Butts PhD, RN
1:15 PMOptimal Nutrition for Cardiovascular Risk Reduction: What should we eat now?
Catherine Christie, PhD, RDN, LDN, FADA, FPCNA
2:05 PMReview of COVID 19: Epidemiology and Cardiovascular Considerations
Yvonne Commodore-Mensah PhD, MHS, RN FAHA, FPCNA
2:50 PMDay 2 Post-learning assessment and Wrap up

Sponsors

PCNA would like to thank the following sponsors for helping to make our program possible:

Premier Sponsors

  • Amgen, Inc.
  • AstraZeneca Pharmaceuticals
  • Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA
  • Esperion Therapeutics, Inc.
  • Janssen
Signature Sponsors
  • Amarin
  • Novo Nordisk, Inc.
  • Pfizer-Merck Alliance
Supporting Sponsor
  • American Heart Association Scientific Councils
    • Cardiovascular and Stroke Nursing
    • Epidemiology and Prevention
    • Lifestyle and Cardiometabolic Health
    • Kidney in Cardiovascular Disease
    • Stroke

Questions? Contact us.

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.